Apostrophe

Apostrophe

Dermatology crafted to you and delivered to your door. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€22—33m (Dealroom.co estimates Dec 2019.)
Oakland California (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Seed

$130k

Seed

N/A

Convertible
N/A

N/A

Seed

$6.0m

Seed

N/A

Acquisition
Total Funding€5.6m

Recent News about Apostrophe

Edit
More about Apostropheinfo icon
Edit

Apostrophe operates in the telehealth market, specializing in dermatology services with a focus on acne treatment. The company serves individuals seeking effective and convenient skincare solutions. Apostrophe's business model revolves around virtual consultations, where patients complete an online assessment reviewed by a board-certified dermatologist. Based on this consultation, a personalized prescription treatment plan is created and delivered directly to the patient's home. The company generates revenue through consultation fees and the sale of prescription medications. Apostrophe differentiates itself by offering continuous support through follow-up visits and medication refills, ensuring patients adhere to their treatment plans. The platform also provides a chat feature for quick responses to patient inquiries, enhancing customer satisfaction and engagement.

Keywords: telehealth, dermatology, acne treatment, virtual consultation, prescription delivery, personalized care, board-certified, skincare solutions, continuous support, patient engagement.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.